Dedong Cao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 27
- Cancer Immunotherapy and Biomarkers 15
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 5
- Inflammatory Biomarkers in Disease Prognosis 5
-
- Cancer, Hypoxia, and Metabolism 6
- MicroRNA in disease regulation 5
Dedong Cao
44 papers receiving 766 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 225
- Oncology 396
- Pulmonary and Respiratory Medicine 205
- Hematology 68
- Hepatology 46
Countries citing papers authored by Dedong Cao
This map shows the geographic impact of Dedong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dedong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dedong Cao more than expected).
Fields of papers citing papers by Dedong Cao
This network shows the impact of papers produced by Dedong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dedong Cao. The network helps show where Dedong Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Dedong Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 25 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 23 | |
| 16 | 2019 | 38 | |
| 17 | 2018 | 13 | |
| 18 | 2016 | 21 | |
| 19 | 2014 | 22 | |
| 20 | 2014 | 10 |
About Dedong Cao
Dedong Cao is a scholar working on Oncology, Cancer Research, Hepatology, Applied Microbiology and Biotechnology and Hematology, having authored 50 papers that have together received 773 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Research Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), MicroRNA in disease regulation (5 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). The work is most often cited by research in Cancer Research (225 citations), Oncology (396 citations), Pulmonary and Respiratory Medicine (205 citations), Hematology (68 citations) and Hepatology (46 citations). Dedong Cao has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Huilin Xu, Wei Ge, Ximing Xu, Tao Guo, Yu Hu, Yu Wen, Huiling Mei, Yongfa Zheng, Qiubai Li and Aihua Liu. Their work appears in journals such as Oncotarget, Oncology Reports, International Immunopharmacology, Scientific Reports and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.